
### [MONDO:0018078](http://purl.obolibrary.org/obo/MONDO_0018078)
**Label:** soft tissue sarcoma

**Subclasses:** [MONDO:0009330](http://purl.obolibrary.org/obo/MONDO_0009330) (hemangiopericytoma, malignant), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0016982](http://purl.obolibrary.org/obo/MONDO_0016982) (angiosarcoma (disease)), [MONDO:0016069](http://purl.obolibrary.org/obo/MONDO_0016069) (undifferentiated pleomorphic sarcoma), [MONDO:0018761](http://purl.obolibrary.org/obo/MONDO_0018761) (SMARCA4-deficient sarcoma of thorax), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0009994](http://purl.obolibrary.org/obo/MONDO_0009994) (alveolar rhabdomyosarcoma (disease)), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0019373](http://purl.obolibrary.org/obo/MONDO_0019373) (desmoplastic small round cell tumor), [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0007300](http://purl.obolibrary.org/obo/MONDO_0007300) (cerebral sarcoma), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0011655](http://purl.obolibrary.org/obo/MONDO_0011655) (alveolar soft part sarcoma (disease)), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0012825](http://purl.obolibrary.org/obo/MONDO_0012825) (extraskeletal myxoid chondrosarcoma), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0012252](http://purl.obolibrary.org/obo/MONDO_0012252) (rhabdoid tumor predisposition syndrome 1), [MONDO:0016238](http://purl.obolibrary.org/obo/MONDO_0016238) (solitary fibrous tumor), [MONDO:0017387](http://purl.obolibrary.org/obo/MONDO_0017387) (epithelioid sarcoma), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0016473](http://purl.obolibrary.org/obo/MONDO_0016473) (familial rhabdoid tumor), [MONDO:0019069](http://purl.obolibrary.org/obo/MONDO_0019069) (rhabdoid tumor), [MONDO:0019202](http://purl.obolibrary.org/obo/MONDO_0019202) (Myxofibrosarcoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0018270](http://purl.obolibrary.org/obo/MONDO_0018270) (extraskeletal Ewing sarcoma), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0017827](http://purl.obolibrary.org/obo/MONDO_0017827) (malignant peripheral nerve sheath tumor), [MONDO:0010434](http://purl.obolibrary.org/obo/MONDO_0010434) (synovial sarcoma (disease)), [MONDO:0016757](http://purl.obolibrary.org/obo/MONDO_0016757) (malignant triton tumor), 

**Corr. equiv. classes:** [Orphanet:79105](http://www.orpha.net/ORDO/Orphanet_79105), [Orphanet:99970](http://www.orpha.net/ORDO/Orphanet_99970), [OMIM:268220](http://purl.obolibrary.org/obo/OMIM_268220), [Orphanet:83469](http://www.orpha.net/ORDO/Orphanet_83469), [Orphanet:99971](http://www.orpha.net/ORDO/Orphanet_99971), [Orphanet:263413](http://www.orpha.net/ORDO/Orphanet_263413), [Orphanet:780](http://www.orpha.net/ORDO/Orphanet_780), [Orphanet:3273](http://www.orpha.net/ORDO/Orphanet_3273), [OMIM:117600](http://purl.obolibrary.org/obo/OMIM_117600), [Orphanet:231108](http://www.orpha.net/ORDO/Orphanet_231108), [Orphanet:293199](http://www.orpha.net/ORDO/Orphanet_293199), [Orphanet:2126](http://www.orpha.net/ORDO/Orphanet_2126), [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [Orphanet:2023](http://www.orpha.net/ORDO/Orphanet_2023), [Orphanet:99969](http://www.orpha.net/ORDO/Orphanet_99969), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [Orphanet:163699](http://www.orpha.net/ORDO/Orphanet_163699), [OMIM:612237](http://purl.obolibrary.org/obo/OMIM_612237), [OMIM:606243](http://purl.obolibrary.org/obo/OMIM_606243), [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276), [Orphanet:209916](http://www.orpha.net/ORDO/Orphanet_209916), [Orphanet:99967](http://www.orpha.net/ORDO/Orphanet_99967), [Orphanet:466962](http://www.orpha.net/ORDO/Orphanet_466962), [OMIM:268210](http://purl.obolibrary.org/obo/OMIM_268210), [Orphanet:31112](http://www.orpha.net/ORDO/Orphanet_31112), [Orphanet:2030](http://www.orpha.net/ORDO/Orphanet_2030), [Orphanet:69078](http://www.orpha.net/ORDO/Orphanet_69078), [Orphanet:252212](http://www.orpha.net/ORDO/Orphanet_252212), [Orphanet:69077](http://www.orpha.net/ORDO/Orphanet_69077), [OMIM:300813](http://purl.obolibrary.org/obo/OMIM_300813), [OMIM:607907](http://purl.obolibrary.org/obo/OMIM_607907), [OMIM:234820](http://purl.obolibrary.org/obo/OMIM_234820), [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:293202](http://www.orpha.net/ORDO/Orphanet_293202), [Orphanet:99756](http://www.orpha.net/ORDO/Orphanet_99756), [Orphanet:99757](http://www.orpha.net/ORDO/Orphanet_99757), [OMIM:609322](http://purl.obolibrary.org/obo/OMIM_609322), [Orphanet:370334](http://www.orpha.net/ORDO/Orphanet_370334), [Orphanet:3148](http://www.orpha.net/ORDO/Orphanet_3148), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 34.96%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 34.54%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 26.63%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 26.53%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 26.53%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 25.24%
- Thing 25.23%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 25.23%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.98%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 22.30%


